Novavax (NVAX) Reports In-Line Q2 EPS

Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.3 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook